High acceptability and viral suppression rate for first-Line patients on a dolutegravir-based regimen: An early adopter study in Nigeria
多替拉韦方案一线治疗患者的接受度高，病毒抑制率高：一项尼日利亚早期采用者研究
期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0284767
Abudiore, Opeyemi; Amamilo, Ikechukwu; Campbell, Jennifer; Eigege, Williams; Harwell, Joseph; Conroy, James; Jiboye, Justus; Lufadeju, Folu; Amole, Carolyn; Wiwa, Owens; Anweh, Damien; Agbaji, Oche Ochai; Akanmu, Alani Sulaimon
